Literature DB >> 18222109

Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury.

Matteo Vidali1, Stephen F Stewart, Emanuele Albano.   

Abstract

Inflammation is recognized increasingly as having an important role in the pathogenesis of alcoholic liver disease (ALD). Nonetheless, the mechanisms by which alcohol maintains hepatic inflammation are still characterized incompletely. Several studies have demonstrated that ethanol-induced oxidative stress promotes immune responses in ALD by stimulating both humoral and cellular reactions against liver proteins adducted to hydroxyethyl free radicals and several lipid peroxidation products. Moreover, ALD patients have autoantibodies targeting cytochrome P4502E1 and oxidized phospholipids. In both chronic alcohol-fed rats and heavy drinkers, the elevation of IgG against lipid peroxidation-derived antigens is associated with tumor necrosis factor-alpha production and the severity of liver inflammation. On this basis, we propose that allo- and autoimmune reactions associated with oxidative stress might contribute to fueling hepatic inflammation in ALD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222109     DOI: 10.1016/j.molmed.2007.12.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  37 in total

1.  Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure.

Authors:  Palash Mandal; Sanjoy Roychowdhury; Pil-Hoon Park; Brian T Pratt; Thierry Roger; Laura E Nagy
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

2.  Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice.

Authors:  Kristofer S Fritz; James J Galligan; Matthew D Hirschey; Eric Verdin; Dennis R Petersen
Journal:  J Proteome Res       Date:  2012-02-21       Impact factor: 4.466

3.  The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes.

Authors:  Pranoti Mandrekar; Shashi Bala; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

4.  Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin.

Authors:  Palash Mandal; Brian T Pratt; Mark Barnes; Megan R McMullen; Laura E Nagy
Journal:  J Biol Chem       Date:  2011-02-25       Impact factor: 5.157

Review 5.  Redox signaling and the innate immune system in alcoholic liver disease.

Authors:  Jessica I Cohen; Xiaocong Chen; Laura E Nagy
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

6.  The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells.

Authors:  Palash Mandal; Pil-Hoon Park; Megan R McMullen; Brian T Pratt; Laura E Nagy
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

Review 7.  A recent perspective on alcohol, immunity, and host defense.

Authors:  Gyongyi Szabo; Pranoti Mandrekar
Journal:  Alcohol Clin Exp Res       Date:  2008-12-02       Impact factor: 3.455

8.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

Review 9.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199.

Authors:  Samantha Yeligar; Hidekazu Tsukamoto; Vijay K Kalra
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.